IBSP and esophageal squamous cell carcinoma: KM analysis demonstrated that the DSS time of ESCC patients with upregulated IBSP (median survival time, 19 months) was shorter than that of ESCC patients with normal IBSP expression (median survival time, 23 months) (P < 0.001; Figure 2A).